{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:22:24Z","timestamp":1697336544538},"reference-count":43,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T00:00:00Z","timestamp":1123459200000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p><jats:bold>Abstract:\u2003<\/jats:bold> Until recently the only available antibiotic eardrops for treatment of the discharging middle ear and mastoid cavity have been potentially ototoxic. With the advent of non\u2010ototoxic fluoroquinolone eardrops, consensus panels in the USA, Canada and the UK have advocated the preferential use of these agents in the open middle ear. However, in Australia, no fluoroquinolone topical agent is approved for use with tympanic membrane perforations, and when used as an \u2018off label\u2019 eardrop, none is on the Pharmaceutical Benefits Scheme. This creates an ethical dilemma, particularly with best practice management of chronic suppurative otitis media in indigenous children. Despite concerns regarding resistance issues with ototopical use of systemic antibiotics, bacterial resistance has not been documented in major studies. For equity and ethical reasons, Australian regulatory authorities should consider approving a sterile non\u2010ototoxic eardrop for use in the open middle ear.<\/jats:p>","DOI":"10.1111\/j.1440-1754.2005.00657.x","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T13:02:34Z","timestamp":1123506154000},"page":"401-404","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ototoxic eardrops and tympanic membrane perforations: Time for a change?"],"prefix":"10.1111","volume":"41","author":[{"given":"Harvey","family":"Coates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,8]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199907000-00015"},{"issue":"1","key":"e_1_2_7_3_2","first-page":"3","article-title":"Characteristics of asystemic and topical agents implicated in toxicity of the middle and inner ear","volume":"82","author":"Roland PS","year":"2003","journal-title":"ENT J."},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S002221510014304X"},{"key":"e_1_2_7_5_2","first-page":"444","article-title":"Topical gentamicin vestibular toxicity","volume":"23","author":"Longridge NS","year":"1994","journal-title":"J. Otolaryngol."},{"key":"e_1_2_7_6_2","first-page":"850","article-title":"Topical gentamicin\u2010induced hearing loss: A mitochondrial ribosomal RNA study of genetic susceptibility","volume":"17","author":"Chen JM","year":"1996","journal-title":"Am. J. Otol."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1998.00161.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200204000-00018"},{"key":"e_1_2_7_9_2","first-page":"357","article-title":"Risk of deafness following ototopical administration of aminoglycoside antibiotic","volume":"35","author":"Dumas G","year":"1980","journal-title":"Therapie"},{"key":"e_1_2_7_10_2","first-page":"653","article-title":"Ototoxicity of ear drops: A clinical perspective","volume":"16","author":"Linder TE","year":"1995","journal-title":"Am. J. Otol."},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000275842"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1998.00161.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459989411000623"},{"key":"e_1_2_7_14_2","first-page":"782","article-title":"Ear ototoxicity: Reality or myth?","volume":"18","author":"Pickett BP","year":"1997","journal-title":"Am. J. Otol."},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199505000-00003"},{"key":"e_1_2_7_16_2","first-page":"141","article-title":"Ototoxicity and ototopical medications: A survey of otolaryngologists","volume":"14","author":"Lundy LB","year":"1993","journal-title":"Am. J. Otol."},{"key":"e_1_2_7_17_2","unstructured":"Canadian Adverse Drug Reation Newsletter.Aminoglycoside ear drops and ototoxicity 7 April 1977 p.3."},{"key":"e_1_2_7_18_2","unstructured":"MIMS Annual.Medi Media MIMS Australia 2004:31251\u20133."},{"key":"e_1_2_7_19_2","volume-title":"Antibiotic Therapeutic Guidelines: Antibiotic","author":"Writing Group for Therapeutic Guidelines","year":"2003"},{"key":"e_1_2_7_20_2","unstructured":"http:\/\/www.health.gov.au\/internet\/wcms\/Publishing.nsf\/Content\/health\u2010oatsih\u2010pubs\u2010omp.htm"},{"key":"e_1_2_7_21_2","unstructured":"IMS Health(Retail sales to pharmacies): Otic anti\u2010infectives (S2A) and Otic corticosteriods\/anti\u2010infective combinations (S2C);Nov 2004."},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5876(89)90051-7"},{"key":"e_1_2_7_23_2","first-page":"215","volume-title":"World Development Report 1993: Investing in Health","author":"World Health Organisation (WHO)","year":"1994"},{"key":"e_1_2_7_24_2","volume-title":"Systematic review of existing evidence and primary care guidelines on the management of otitis media in Aboriginal and Torres Strait Islander Populations","author":"Couzos S","year":"2001"},{"issue":"11","key":"e_1_2_7_25_2","first-page":"893","article-title":"The aetiology and prevention of otitis media in Aboriginal children in the NT, Australia (Thesis)","volume":"105","author":"Foreman AEW","year":"1987","journal-title":"Ann. Otol. Rhinol. Laryngol"},{"key":"e_1_2_7_26_2","unstructured":"ForemanA BoswellJ MathewsJ.Prevalence of otitis media in Aboriginal children of pre\u2010school age in three Northern Territory rural communities.Proceedings of the Medical Options for Prevention and Treatment of Otitis Media in Australian Aboriginal Infants; 16\u201318 Feb 1992 Menzies School of Health Research and Australian Doctors Fund 1992:46\u201355."},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(86)90041-X"},{"key":"e_1_2_7_28_2","first-page":"67","article-title":"Hearing loss in Australian Aborigines: A critical evaluation","volume":"12","author":"McPherson B","year":"1990","journal-title":"Aust. J. Audiol."},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.1997.tb01670.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7412.415"},{"key":"e_1_2_7_31_2","volume-title":"The Cochrane Library","author":"Acuin J","year":"2002"},{"key":"e_1_2_7_32_2","first-page":"185","article-title":"Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: A community based, multicentre, double\u2010blind randomised controlled trial","volume":"179","author":"Couzos S","year":"2003","journal-title":"Med. J. Asut."},{"key":"e_1_2_7_33_2","first-page":"14","article-title":"Reminder: Ototoxicity with aminoglycoside eardrops","volume":"23","author":"Committee on Safety of Medicines","year":"1997","journal-title":"Curr. Prob. Pharmacovigilance"},{"key":"e_1_2_7_34_2","volume-title":"Anti\u2010Infective Guidelines for Community Acquired Infections","author":"Pilla NJ","year":"2001"},{"key":"e_1_2_7_35_2","first-page":"S51","article-title":"Efficacy and safety of topical antibiotics in the treatment of ear disease: Consensus panel update 2004","volume":"130","author":"Special Consensus Panel of the American Academy of Otolaryngology \u2013 Head and Neck Surgery","year":"2004","journal-title":"Otolaryngol. \u2013 Head and Neck Surg."},{"issue":"14","key":"e_1_2_7_36_2","first-page":"S345","article-title":"Strategies for decreasing multidrug antibiotic resistance: Role of ototopical agents for treatment of middle ear infection","volume":"8","author":"Klein JO","year":"2002","journal-title":"Am. J. Manage. Care"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80137-9"},{"key":"e_1_2_7_38_2","first-page":"207","article-title":"In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics","volume":"17","author":"Dohar JG","year":"1996","journal-title":"Am. J. Otol."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890120070014"},{"key":"e_1_2_7_40_2","first-page":"18","article-title":"The treatment of chronic suppurative otitis media and otitis externa with 0.3% ofloxacin otic solution: A clinicomicrobiological study","volume":"78","author":"Supiyaphun P","year":"1995","journal-title":"J. Med. Assoc. Thai"},{"key":"e_1_2_7_41_2","unstructured":"RolandP StromanDW ConroyP.Topical therapy treatment failures in children with acute otitis media with otorrhea draining through a tympanostomy tube. In:LimD BluestoneC CasselbrantLet al. (eds) Proceedings of the Ninth International Symposium: Recent Advances in Otitis Media. Florida :Fort Lauderdale 2004(in press)."},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.3.337"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890080048009"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.126.2.165"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1754.2005.00657.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1754.2005.00657.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:30:34Z","timestamp":1696890634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1754.2005.00657.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1440-1754.2005.00657.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1754.2005.00657.x","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"2005-08-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}